IMBCAMS reveals Phase 2 clinical trial of COVID-19 vaccine in China
Date: 2020-06-22   Author: Saipriya Iyer  Category: #news

IMBCAMS reveals Phase 2 clinical trial of COVID-19 vaccine in China

The IMB (Institute of Medical Biology) at the CAMS (Chinese Academy of Medical Sciences) has recently stated that Chinese researchers have started the Phase 2 COVID-19 vaccine trial. The 2nd phase of this potential coronavirus vaccine has been commenced to examine its safety and effectiveness.

There are nearly a dozen COVID-19 vaccines that are currently under the human trial phase across the globe. The WHO (World Health Organization) has informed about the accelerating cases and impacts of the coronavirus pandemic, which has reshaped the global order and placed people at higher risks. In the wake of this pandemic, however, no vaccines have passed the late-stage, large scale Phase 3 clinical trial, the crucial step needed prior to getting the regulatory approval for selling the vaccine globally.

Among other researchers, the IMBCAMS has recently begun the Phase 2 human trial for the experimental study. The vaccine that is currently under trial is among the six vaccines that are being developed by the Chinese researchers against the COVID-19 vaccine.

The institute has reportedly stated that nearly 200 participants were included in the 1st phase of the vaccine trial that was conducted in May. This Phase 2 trial will target to emphasize on the immune responses among healthy patients while determining the dose of the vaccine. It also stated its aim to adopt a plant for producing the COVID-19 vaccine in 2020, which in turn, will help in preparing the future vaccine supplies in China.

According to Gao Fu, Director of China CDC (Chinese Center for Disease Control & Prevention), some groups of high-risk special needs patients can use the experimental vaccine under urgent circumstances by 2020 end.

The pandemic, which was discovered for the 1st time in late 2019, has impacted nearly 8.81 million and claimed the lives of over 460,000 people across the globe.

Source credit:

https://www.thehindubusinessline.com/news/world/china-begins-phase-2-of-the-clinical-trial-for-potential-covid-19-vaccine/article31882148.ece



About Author


Saipriya Iyer

Saipriya Iyer

Saipriya Iyer currently works as a content developer for AlgosOnline. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her belt, she has dabbled with website...

Read More

More from Saipriya


Post Recommendents

Global Reagent Grade Solketal Market - Growth, Trends and Forecast (2019 - 2025)
Author: Partha Ray

"MarketStudyReport.com adds Global Reagent Grade Solketal Industry Market research focusing on the major drivers and restraints for the key players. It also provides analysis of the market share, segmentation, revenue forecasts and geographic...


Packaged Bakery Products Market: Global Demand Analysis & Opportunity Outlook 2025
Author: Partha Ray

"Market Study Report adds New Global Packaged Bakery Products Industry Market research providing in-depth information about market overview, top vendors, Key market highlights, product types, market drivers, challenges, trends, Packaged Baker...


bicycle riders gears Market Trends and Prospects by 2025
Author: Partha Ray

"bicycle riders gears Industry market report gives attention to market segmentation, market size, and forecast of 2020-2025 to help stakeholders in making a good decision for the future investments. bicycle riders gears Industry industry repo...